Trial NCT03605212

View at ClinicalTrials.gov 
Org. Study IDs: FLO-02
Secondary IDs: 2016-001445-61

Last trial update was posted on 2021-06-03

MeSH Interventions

Febuxostat

MeSH Conditions

Syndrome Tumor Lysis Syndrome

Other Conditions


Stopping Reasons

The study was stopped as per EMA waiver granted on 20July2018.

Limitations And Caveats

Data for all outcome measures were not collected due to the paucity of data in the minor patient population and in agreement with EMA with the exceptions of the secondary outcome Assessment of Treatment Emergent Signs and Symptoms (TESS).

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID